LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 3 von insgesamt 3

Suchoptionen

  1. Artikel ; Online: Ebselen as template for stabilization of A4V mutant dimer for motor neuron disease therapy.

    Chantadul, Varunya / Wright, Gareth S A / Amporndanai, Kangsa / Shahid, Munazza / Antonyuk, Svetlana V / Washbourn, Gina / Rogers, Michael / Roberts, Natalie / Pye, Matthew / O'Neill, Paul M / Hasnain, S Samar

    Communications biology

    2020  Band 3, Heft 1, Seite(n) 97

    Abstract: Mutations to the gene encoding superoxide dismutase-1 (SOD1) were the first genetic elements discovered that cause motor neuron disease (MND). These mutations result in compromised SOD1 dimer stability, with one of the severest and most common mutations ... ...

    Abstract Mutations to the gene encoding superoxide dismutase-1 (SOD1) were the first genetic elements discovered that cause motor neuron disease (MND). These mutations result in compromised SOD1 dimer stability, with one of the severest and most common mutations Ala4Val (A4V) displaying a propensity to monomerise and aggregate leading to neuronal death. We show that the clinically used ebselen and related analogues promote thermal stability of A4V SOD1 when binding to Cys111 only. We have developed a A4V SOD1 differential scanning fluorescence-based assay on a C6S mutation background that is effective in assessing suitability of compounds. Crystallographic data show that the selenium atom of these compounds binds covalently to A4V SOD1 at Cys111 at the dimer interface, resulting in stabilisation. This together with chemical amenability for hit expansion of ebselen and its on-target SOD1 pharmacological chaperone activity holds remarkable promise for structure-based therapeutics for MND using ebselen as a template.
    Mesh-Begriff(e) Amino Acid Substitution/genetics ; Azoles/chemical synthesis ; Azoles/chemistry ; Azoles/pharmacology ; Azoles/therapeutic use ; Crystallography, X-Ray ; Drug Design ; Drug Discovery/methods ; Drug Evaluation, Preclinical/methods ; Humans ; Isoindoles ; Models, Molecular ; Molecular Chaperones/chemical synthesis ; Molecular Chaperones/chemistry ; Molecular Chaperones/therapeutic use ; Molecular Docking Simulation ; Motor Neuron Disease/drug therapy ; Motor Neuron Disease/genetics ; Motor Neuron Disease/metabolism ; Motor Neuron Disease/pathology ; Mutant Proteins/chemistry ; Mutant Proteins/drug effects ; Mutant Proteins/genetics ; Mutant Proteins/metabolism ; Mutation, Missense ; Organoselenium Compounds/chemical synthesis ; Organoselenium Compounds/chemistry ; Organoselenium Compounds/isolation & purification ; Organoselenium Compounds/pharmacology ; Organoselenium Compounds/therapeutic use ; Protein Folding/drug effects ; Protein Multimerization/drug effects ; Protein Stability/drug effects ; Protein Structure, Tertiary ; Sulfur Compounds/chemical synthesis ; Sulfur Compounds/chemistry ; Superoxide Dismutase-1/chemistry ; Superoxide Dismutase-1/drug effects ; Superoxide Dismutase-1/genetics ; Superoxide Dismutase-1/metabolism ; Thermodynamics
    Chemische Substanzen Azoles ; Isoindoles ; Molecular Chaperones ; Mutant Proteins ; Organoselenium Compounds ; SOD1 protein, human ; Sulfur Compounds ; ebsulfur ; ebselen (40X2P7DPGH) ; Superoxide Dismutase-1 (EC 1.15.1.1)
    Sprache Englisch
    Erscheinungsdatum 2020-03-05
    Erscheinungsland England
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 2399-3642
    ISSN (online) 2399-3642
    DOI 10.1038/s42003-020-0826-3
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: Repurposing and Reformulation of the Antiparasitic Agent Flubendazole for Treatment of Cryptococcal Meningoencephalitis, a Neglected Fungal Disease.

    Nixon, Gemma L / McEntee, Laura / Johnson, Adam / Farrington, Nicola / Whalley, Sarah / Livermore, Joanne / Natal, Cristien / Washbourn, Gina / Bibby, Jaclyn / Berry, Neil / Lestner, Jodi / Truong, Megan / Owen, Andrew / Lalloo, David / Charles, Ian / Hope, William

    Antimicrobial agents and chemotherapy

    2018  Band 62, Heft 4

    Abstract: Current therapeutic options for cryptococcal meningitis are limited by toxicity, global supply, and emergence of resistance. There is an urgent need to develop additional antifungal agents that are fungicidal within the central nervous system and ... ...

    Abstract Current therapeutic options for cryptococcal meningitis are limited by toxicity, global supply, and emergence of resistance. There is an urgent need to develop additional antifungal agents that are fungicidal within the central nervous system and preferably orally bioavailable. The benzimidazoles have broad-spectrum antiparasitic activity but also have
    Mesh-Begriff(e) Animals ; Antifungal Agents/therapeutic use ; Antiparasitic Agents/therapeutic use ; Benzimidazoles/therapeutic use ; Cryptococcosis/drug therapy ; Cryptococcosis/microbiology ; Cryptococcus neoformans/drug effects ; Cryptococcus neoformans/pathogenicity ; Drug Repositioning/methods ; Female ; Fluconazole/therapeutic use ; Male ; Mebendazole/analogs & derivatives ; Mebendazole/therapeutic use ; Meningitis, Cryptococcal/drug therapy ; Meningitis, Cryptococcal/microbiology ; Mice ; Microbial Sensitivity Tests ; Mycoses/drug therapy ; Mycoses/microbiology ; Rabbits ; Rats ; Swine
    Chemische Substanzen Antifungal Agents ; Antiparasitic Agents ; Benzimidazoles ; Mebendazole (81G6I5V05I) ; Fluconazole (8VZV102JFY) ; benzimidazole (E24GX49LD8) ; flubendazole (R8M46911LR)
    Sprache Englisch
    Erscheinungsdatum 2018-03-27
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 217602-6
    ISSN 1098-6596 ; 0066-4804
    ISSN (online) 1098-6596
    ISSN 0066-4804
    DOI 10.1128/AAC.01909-17
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: Carbamoyl Triazoles, Known Serine Protease Inhibitors, Are a Potent New Class of Antimalarials.

    McConville, Matthew / Fernández, Jorge / Angulo-Barturen, Íñigo / Bahamontes-Rosa, Noemi / Ballell-Pages, Lluis / Castañeda, Pablo / de Cózar, Cristina / Crespo, Benigno / Guijarro, Laura / Jiménez-Díaz, María Belén / Martínez-Martínez, Maria S / de Mercado, Jaime / Santos-Villarejo, Ángel / Sanz, Laura M / Frigerio, Micol / Washbourn, Gina / Ward, Stephen A / Nixon, Gemma L / Biagini, Giancarlo A /
    Berry, Neil G / Blackman, Michael J / Calderón, Félix / O'Neill, Paul M

    Journal of medicinal chemistry

    2015  Band 58, Heft 16, Seite(n) 6448–6455

    Abstract: Screening of the GSK corporate collection, some 1.9 million compounds, against Plasmodium falciparum (Pf), revealed almost 14000 active hits that are now known as the Tres Cantos Antimalarial Set (TCAMS). Followup work by Calderon et al. clustered and ... ...

    Abstract Screening of the GSK corporate collection, some 1.9 million compounds, against Plasmodium falciparum (Pf), revealed almost 14000 active hits that are now known as the Tres Cantos Antimalarial Set (TCAMS). Followup work by Calderon et al. clustered and computationally filtered the TCAMS through a variety of criteria and reported 47 series containing a total of 522 compounds. From this enhanced set, we identified the carbamoyl triazole TCMDC-134379 (1), a known serine protease inhibitor, as an excellent starting point for SAR profiling. Lead optimization of 1 led to several molecules with improved antimalarial potency, metabolic stabilities in mouse and human liver microsomes, along with acceptable cytotoxicity profiles. Analogue 44 displayed potent in vitro activity (IC50 = 10 nM) and oral activity in a SCID mouse model of Pf infection with an ED50 of 100 and ED90 of between 100 and 150 mg kg(-1), respectively. The results presented encourage further investigations to identify the target of these highly active compounds.
    Mesh-Begriff(e) Animals ; Antimalarials/chemical synthesis ; Antimalarials/metabolism ; Antimalarials/pharmacology ; High-Throughput Screening Assays ; Humans ; In Vitro Techniques ; Malaria/drug therapy ; Malaria/psychology ; Malaria, Falciparum/drug therapy ; Mice ; Mice, SCID ; Microsomes, Liver/metabolism ; Plasmodium berghei/drug effects ; Plasmodium falciparum/drug effects ; Serine Proteinase Inhibitors/chemical synthesis ; Serine Proteinase Inhibitors/metabolism ; Serine Proteinase Inhibitors/pharmacology ; Structure-Activity Relationship ; Triazoles/chemical synthesis ; Triazoles/metabolism ; Triazoles/pharmacology
    Chemische Substanzen Antimalarials ; Serine Proteinase Inhibitors ; Triazoles
    Sprache Englisch
    Erscheinungsdatum 2015-08-17
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 218133-2
    ISSN 1520-4804 ; 0022-2623
    ISSN (online) 1520-4804
    ISSN 0022-2623
    DOI 10.1021/acs.jmedchem.5b00434
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang